Five-Plus Year Follow-Up of SMART Randomized Controlled Trial
CompletedNCT03997825
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The objective of this study is to evaluate long-term ongoing effectiveness of the Intracept Intraosseous Nerve Ablation System for the treatment of chronic low back pain.
Study details
- Official title
- Five-Plus Year Follow-Up of SMART (Surgical Multicenter Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain) Trial
- Conditions
- Interventions
- Device: Basivertebral Nerve (BVN) Ablation
- Sponsor
- Relievant Medsystems, Inc.
- Start date
- 2019-06-13
- Primary completion
- 2019-11-08
- Sex
- All
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 13
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * LBP at least 6 months from original SMART Trial * RF Ablation Arm from SMART Trial Exclusion Criteria: -Control Arm Subjects from SMART Trial
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03997825